Company intelligence / Profile preview

Helm Capital Group

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Helm Capital Group, Inc. was a publicly traded investment holding company that historically managed a diversified portfolio of assets. While the company has been associated with various industrial and financial investments, it is not a primary developer of biotechnology or pharmaceutical products. In recent years, the entity has largely become inactive or transitioned into a shell company, with its ticker symbols appearing in historical micro-cap and Pink Sheet listings. It should not be confused with HELM AG, a major German life sciences and chemical distribution company, or The Helm, a venture capital firm focused on female-founded healthcare startups.

Industry: Investors

Beyond the preview

Go deeper on Helm Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helm Capital Group.

Explore the full profile